Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Safi R. Bahcall currently holds 2,053,135 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Safi R. Bahcall has been a net buyer of SNTA stock. They have purchased $662.2K and sold $0 worth of shares.
Safi R. Bahcall's most recent insider trade was on Nov 13, 2013, when they purchased 20,000 shares at $3.75 per share.
Safi R. Bahcall serves as Executive at SYNTA PHARMACEUTICALS CORP (SNTA). They have executed 31 insider transactions totaling $662.2K over their tenure at the company.
Safi R. Bahcall holds the position of Executive at SYNTA PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Safi R. Bahcall has shown a buying trading pattern, with $662.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Safi R. Bahcall was on Jul 25, 2012, when they purchased $129.8K worth of SNTA shares. This transaction involved 20,000 shares at $6.49 per share.
Safi R. Bahcall currently owns 2,053,135 shares of SYNTA PHARMACEUTICALS CORP (SNTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Safi R. Bahcall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Safi R. Bahcall has 31 Form 4 filings on record as an insider at SYNTA PHARMACEUTICALS CORP.
Set alerts for Safi R. Bahcall and 40,000+ other insiders.